Indaptus Therapeutics (INDP) Insider Trading & Ownership $0.38 0.00 (-0.16%) Closing price 03:51 PM EasternExtended Trading$0.41 +0.03 (+8.07%) As of 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Indaptus Therapeutics (NASDAQ:INDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.50%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$243,983.73Number OfInsiders Selling(Last 3 Years)0 Get INDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INDP Insider Buying and Selling by Quarter Indaptus Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2023Glen R AndersonMajor ShareholderBuy23,934$2.34$56,005.56 8/10/2023Glen R AndersonMajor ShareholderBuy44,354$1.94$86,046.76 12/1/2022Boyan Vesselinov LitchevInsiderBuy500$1.87$935.00 11/22/2022Boyan Vesselinov LitchevInsiderBuy500$1.83$915.00 11/21/2022Jeffrey A MecklerCEOBuy9,600$1.90$18,240.00 11/18/2022Jeffrey A MecklerCEOBuy400$1.76$704.00 9/8/2022Jeffrey A MecklerCEOBuy10,308$2.80$28,862.40 9/7/2022Walt Addison LinscottInsiderBuy150$2.62$393.00 6/6/2022Jeffrey A MecklerCEOBuy19,727$2.63$51,882.01 (Data available from 1/1/2013 forward) INDP Insider Trading Activity - Frequently Asked Questions Who is on Indaptus Therapeutics's Insider Roster? The list of insiders at Indaptus Therapeutics includes Boyan Vesselinov Litchev, Glen R Anderson, Jeffrey A Meckler, and Walt Addison Linscott. Learn more on insiders at INDP. What percentage of Indaptus Therapeutics stock is owned by insiders? 29.50% of Indaptus Therapeutics stock is owned by insiders. Learn more on INDP's insider holdings. Which Indaptus Therapeutics insiders have been buying company stock? The following insider purchased INDP shares in the last 24 months: Glen R Anderson ($142,052.32). How much insider buying is happening at Indaptus Therapeutics? Insiders have purchased a total of 68,288 INDP shares in the last 24 months for a total of $142,052.32 bought. Indaptus Therapeutics Key ExecutivesMr. Jeffrey A. Meckler (Age 57)CEO & Director Compensation: $867.03kDr. Michael J. Newman Ph.D. (Age 68)Founder, Chief Scientific Officer & Director Compensation: $659.99kMr. Walt Addison Linscott Esq. (Age 63)Chief Operating Officer Compensation: $716.35kMr. Nir Sassi (Age 48)CFO, Secretary & Treasurer Compensation: $378.47kDr. Roger J. Waltzman M.B.A. (Age 56)M.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies Surrozen Insider Transactions OnKure Therapeutics Insider Transactions Generation Bio Insider Transactions Cadrenal Therapeutics Insider Transactions BioAtla Insider Transactions Clene Insider Transactions Cara Therapeutics Insider Transactions Cyclo Therapeutics Insider Transactions Tempest Therapeutics Insider Transactions CASI Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Turbulence for Joby Shares: What's Behind the Recent Dip?UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market Cap This page (NASDAQ:INDP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indaptus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Indaptus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INDP Stock Free INDP Stock Alerts